Stem Cell Revolution

Hope Biosciences

Stem Cell Revolution is your front-row seat to the future of medicine! Hosted by the team at Hope Biosciences, this podcast brings you the latest in this ever evolving field. We don’t just talk about breakthroughs, we document them in real time. From groundbreaking clinical trials to patient stories and regulatory shifts, we’re living the revolution as it happens. Join us as we explore how stem cells are transforming medicine, challenging outdated paradigms, and shaping a new era in healthcare. This is more than a podcast—it’s a movement. Subscribe now and experience the revolution with us!

  1. Are Stem Cells Worth The Money? | Stem Cell Revolution | Episode 26

    5D AGO

    Are Stem Cells Worth The Money? | Stem Cell Revolution | Episode 26

    Why Are Stem Cells So Expensive? The Real Cost Breakdown in 2026 In this episode of Stem Cell Revolution, Donna Chang and Jan Shultis tackle one of the most common and uncomfortable questions in regenerative medicine: Why do stem cell treatments cost so much? From $5,000 cash-pay clinic procedures… to $25,000 overseas medical tourism visits… to FDA-approved cellular therapies costing $200,000 to $400,000 — we break down exactly what you’re paying for and why. This isn’t just a conversation about price tags. It’s about transparency, access, safety, and the future of affordable regenerative medicine. In this episode, we cover: • The difference between same-day procedures and true manufactured cell products • Why many “stem cell” products in the U.S. contain no viable stem cells • The hidden costs behind overseas treatments and medical tourism • Why FDA-approved therapies cost hundreds of thousands of dollars • The real reason hospital-based cellular therapies are so expensive • How research, testing, and regulatory safeguards impact pricing • The economics of chronic disease vs regenerative therapy We also discuss real examples, including: • Hematopoietic stem cell transplants and why they can cost $400,000 • FDA-approved orthopedic and pediatric cellular therapies • The recent Mesoblast approval for acute GvHD • The long-term financial burden of diseases like Parkinson’s, MS, and rheumatoid arthritis Then we turn to the bigger question: Is there a way to make stem cell therapy both safe AND affordable? Donna shares how Hope Biosciences approached the problem differently by focusing first on safety, speed, and standardization to dramatically reduce manufacturing costs without sacrificing quality. We break down what a monthly regenerative treatment model could look like compared to current biologic drug costs of $60,000 to $100,000 per year. If you’ve ever wondered: • Why aren’t stem cells covered by insurance? • Why do some treatments cost $5,000 and others $200,000? • Is overseas treatment worth the risk? • Can regenerative medicine ever be truly accessible? This episode is essential listening. The future of stem cell therapy isn’t just about science. It’s about affordability, scalability, and real-world access. We’d love to hear your thoughts. Drop your questions in the comments and let us know what topics you want us to cover next. #StemCellRevolution #RegenerativeMedicine #StemCells #CellTherapy #HealthcareCosts #FDA #Biologics #MedicalInnovation #HopeBiosciences

    1h 4m
  2. Cord Blod: Miracle or Marketing? | Stem Cell Revolution | Episode 22

    10/15/2025

    Cord Blod: Miracle or Marketing? | Stem Cell Revolution | Episode 22

    Is cord blood banking the biggest stem cell scam of all time? We dive deep into the science to answer this question once and for all. Episode Resources: July 15, 2024 New York Times article " “Promised Cures, Tainted Cells: How Cord Blood Banks Mislead Parents” by investigative reporter Sarah Kliff and Azeen Ghorayshi https://www.nytimes.com/2024/07/15/health/cord-blood-storage-contamination.htmlResponse to the article by the Cord Blood Association: https://www.cb-association.org/assets/docs/CBA%20Letter%20to%20the%20Editor%20of%20the%20New%20York%20Times_7.16.24.pdfParent's Guide to Cord Blood - Odds of Using Cord Bloodhttps://parentsguidecordblood.org/en/oddsAmerican College of Obstetricians & Gynecologists (ACOG) Opinionhttps://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2019/03/umbilical-cord-blood-bankingAmerican Academy of Pediatrics (AAP) Policy Statement https://publications.aap.org/pediatrics/article/140/5/e20172695/37866/Cord-Blood-Banking-for-Potential-Future?autologincheck=redirectedWorld Marrow Donor Association (WMDA) Policy Statementhttps://bloodstemcell.hrsa.gov/sites/default/files/bloodstemcell/donor-information/word-marrow-donor-association.pdfThe European Group on Ethics in Science and New Technologies (EGE) Opinionhttps://ec.europa.eu/commission/presscorner/detail/en/ip_04_364Have questions about what we do? Learn about the hope banking process and put us to the test! Watch now on YouTube!https://youtu.be/man4k1uUmeA?si=99tvV-0pQsk-AzC9https://youtu.be/0lnvlEAmrtg?si=l_cXROe1-H_eB0Do💡 Have questions? Leave them in the comments—we read every one!👍 Don’t forget to like, subscribe, and share to help more families make informed choices.#CordBlood #StemCells #CellTherapy #PublicDonation #PrivateBanking #ParentingScience #MedicalResearch

    58 min
  3. Stem Cell Censorship | Stem Cell Revolution | Episode 21

    09/15/2025

    Stem Cell Censorship | Stem Cell Revolution | Episode 21

    If stem cells are so great, why don’t you hear more about them? In this episode of Stem Cell Revolution, hosts Donna Chang and Jan Shultis dive into the hidden barriers that keep groundbreaking science out of the spotlight. From the medical establishment to the world of peer reviewed literature, Donna and Jan pull back the curtain on the censorship challenges facing regenerative medicine today.What you’ll learn in this episode:- Why your doctor may not be equipped to answer your questions about stem cells- How the peer review process affects access to information- Digital barriers making it so hard to find accurate information💡 If you’ve ever wondered why you’ve never heard about certain breakthroughs, this episode is a must-watch.Read our RA Study Paper: https://pmc.ncbi.nlm.nih.gov/articles/PMC8896321/Pumpkin Pie Crochet Coaster Drawing! In celebration of Giving Tuesday, every donation given here https://www.hopebio.org/donate will be automatically entered to win. Donations made from 09/12/2025 to 12/2/2025 will be eligible. Every dollar donated to the Hope Biosciences Research Foundation supports stem cell research in the form of human clinical trials. These trials make a direct impact to the lives of those suffering from incurable conditions. Thank you for your support!👉 Don’t forget to like, comment!🔔 Subscribe for more episodes of the Stem Cell Revolution.📍 Produced by Hope BiosciencesLinks:HOPE STORE: https://www.hope.bio/merchWEBSITE - https://www.hope.bioINSTAGRAM - / hope.bioTWITTER - / hopebiosciencesFACEBOOK - / hopebiosciences#StemCells #Censorship #RegenerativeMedicine #HopeBiosciences #StemCellRevolution

    52 min
  4. 07/15/2025

    Are Stem Cell Rules Finally Changing? | Stem Cell Revolution | Episode 19

    Is the FDA finally loosening its grip on regenerative medicine?In this landmark episode, Donna Chang and Jan Shultis break down the major regulatory shakeups coming out of Washington—from the removal of CAR-T safety barriers to RFK Jr.’s sweeping promises to “clear the path” for innovation. With high-profile figures like Dr. Vinay Prasad and Dr. Carl June calling for less FDA oversight and faster approvals, it seems the tide is turning for cell and gene therapy pioneers.🔍 Topics We Cover:• Highlights from the June 5 CBER Roundtable• RFK Jr.'s new health leadership team and policy vision• Why Carl June wants early-stage CGT trials to skip FDA• Real-world impacts of the REMS removal for CAR-T• Why U.S. trials involving foreign labs are being halted• The rise of AI in drug approvals—helpful or dangerous?• The role of the new FDA Office of Therapeutic Products (OTP)• What it all means for autologous stem cell therapy💡 If you’re in the biotech, clinical research, or regenerative medicine space, this is essential listening. The rules are shifting—and your ability to deliver breakthrough therapies may finally get the green light.👇 Drop your thoughts in the comments:Is less regulation good for innovation? Or are we heading into risky territory?🔔 Subscribe for more episodes of the Stem Cell Revolution.📍 Produced by Hope BiosciencesLinks:WEBSITE - https://www.hope.bioINSTAGRAM -   / hope.bio  TWITTER -   / hopebiosciences  FACEBOOK -   / hopebiosciences   #StemCellRevolution #RegenerativeMedicine #RFKjr #CAR_T #FDAupdates #CellTherapy #GeneTherapy #Autologous #CBER #HopeBiosciences

    52 min

Ratings & Reviews

5
out of 5
3 Ratings

About

Stem Cell Revolution is your front-row seat to the future of medicine! Hosted by the team at Hope Biosciences, this podcast brings you the latest in this ever evolving field. We don’t just talk about breakthroughs, we document them in real time. From groundbreaking clinical trials to patient stories and regulatory shifts, we’re living the revolution as it happens. Join us as we explore how stem cells are transforming medicine, challenging outdated paradigms, and shaping a new era in healthcare. This is more than a podcast—it’s a movement. Subscribe now and experience the revolution with us!